Here are what the editors at HealthDay consider to be the most important developments in Urology for September 2020. This roundup includes the latest research news from journal articles, as …
September 2020 Briefing – Otolaryngology
Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for September 2020. This roundup includes the latest research news from journal articles, as …
September 2020 Briefing – Nephrology
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for September 2020. This roundup includes the latest research news from journal articles, as …
September 2020 Briefing – Anesthesiology
Here are what the editors at HealthDay consider to be the most important developments in Anesthesiology for September 2020. This roundup includes the latest research news from journal articles, as …
September 2020 Briefing – Cosmetic Surgery
Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for September 2020. This roundup includes the latest research news from journal articles, …
September 2020 Briefing – Geriatrics
Here are what the editors at HealthDay consider to be the most important developments in Geriatrics for September 2020. This roundup includes the latest research news from journal articles, as …
September 2020 Briefing – Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for September 2020. This roundup includes the latest research news from journal articles, …
September 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2020. This roundup includes the latest research news from journal articles, as …
Bronchitis in Early Childhood Linked to Later Lung Disease
Lung diseases occurring later in life more likely to be asthma, pneumonia rather than chronic bronchitis
No Moderna COVID-19 Vaccine Expected Until Next Spring
Company will not be ready to seek U.S. approval for the vaccine until at least late January